Expression,Purification and Functional Evaluation of Neorudin-Human IgG-Fc Fusion Protein
Zuze Wu,Kun Wang,Shichong Li,Xiaona Dong,Guifang Dou,Zhiqiang Ge,Jide Jin
DOI: https://doi.org/10.11784/tdxbz201803084
2019-01-01
Abstract:Neorudin(EH)has a good anticoagulant effect.However,the short half-life of EH limits its clinical popu-larization and application.To prolong the half-life of EH,fusion proteins of Fc segment of human IgG and EH were prepared and the anticoagulant activity and pharmacokinetics of the fusion proteins were studied.The fusion genes Fc-EH and Fc-L-EH were cloned into the expression vector pcDNAHC and expressed in CHO cells.The fusion proteins were purified by protein A affinity chromatography and identified by SDS-PAGE and Western Blot.The molecular mass and C-terminal amino acid sequences of the fusion proteins were detected using mass spectrometry.The antico-agulant activities of fusion proteins in vitro and in vivo were detected with clot methods and jugular vein thrombosis rat models,respectively.The half-life of the fusion protein was tested in rats by chemiluminescence immunoas-say.The results of restriction enzyme reaction indicated that the two recombinant expression vectors pcDNAHC-Fc-EH and pcDNAHC-Fc-L-EH were constructed,and the molecular masses of two targeting proteins were measured 68,476,u and 70,542,u,respectively.The correct C-terminal amino acid sequences of the fusion proteins were ob-tained.The anticoagulant activity of the fusion protein Fc-EH is 256 ATU/mg,whereas that of Fc-L-EH is 64 ATU/mg.The results of jugular vein thrombosis rat models indicated that the fusion proteins of Fc-EH dose-dependently inhibited thrombosis.In vivo pharmacokinetic,studies showed that the elimination half-life of Fc-EH spanned 39.4,h.These results demonstrate that the Fc-EH fusion protein prolongs the half-life of EH,paving the way for the further studies of its anticoagulant effects.